Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1995 Oct;141(2):465-79.
doi: 10.1093/genetics/141.2.465.

Isolation of mutants of Saccharomyces cerevisiae requiring DNA topoisomerase I

Affiliations
Comparative Study

Isolation of mutants of Saccharomyces cerevisiae requiring DNA topoisomerase I

B U Sadoff et al. Genetics. 1995 Oct.

Abstract

Despite evidence that DNA topoisomerase I is required to relieve torsional stress during DNA replication and transcription, yeast strains with a top1 null mutation are viable and display no gross defects in DNA or RNA synthesis, possibly because other proteins provide overlapping functions. We isolated mutants whose inviablility or growth defect is relieved when TOP1 is expressed [trf mutants (topoisomerase one-requiring function)]. The TRF genes define at least four complementation groups. TRF3 is allelic to TOP2. TRF1 is allelic to HPR1, previously shown to be homologous to TOP1 over two short regions. TRF4 encodes a novel 584-amino acid protein with homology to the N-terminus of Saccharomyces cerevisiae topo I. Like top1 mutants, trf4 mutants have elevated rDNA recombination and fail to shut off RNA polymerase II transcription in stationary phase. trf4 null mutants are cs for viability, display reduced expression of GAL1 and Cell Cycle Box UAS::LacZ fusions, and are inviable in combination with trfI null mutants, indicating that both proteins may share a common function with DNA topoisomerase I. The existence of multiple TRF complementation groups suggests that not all biological functions of topo I can be carried out by topo II.

PubMed Disclaimer

References

    1. Cell. 1989 Apr 21;57(2):295-303 - PubMed
    1. J Cell Biol. 1989 Feb;108(2):243-53 - PubMed
    1. Genetics. 1989 May;122(1):19-27 - PubMed
    1. Cell. 1989 Jul 28;58(2):409-19 - PubMed
    1. J Mol Biol. 1989 Jul 20;208(2):257-67 - PubMed

Publication types

MeSH terms

Substances

Associated data